ARTICLE | Clinical News
Protarga starts Taxoprexin Phase II trials
October 31, 2001 8:00 AM UTC
Protarga (King of Prussia, Penn.) began 2 U.S. Phase II trials of its Taxoprexin DHA-paclitaxel to treat hormone-refractory prostate cancer and advanced breast cancer. The trials are part of a previou...